Information supplied here is not intended to replace advice from your doctor. Our products are not intended to diagnose, treat, prevent or cure any disease.
Autism is a disorder that affects the development of the brain. This is characterised by repetitive sometimes damaging behaviour and problems with social interaction and communication. As of today, the management of this condition is heavily geared towards coaching and drug medication. While there has been a limited study that will prove that cannabis oil has a positive impact on autism, there is currently growing positive evidence based on the testimony of parents and medical professionals.
The Current Dilemma of Using Cannabis Oil for Autism
While there has been increasing evidence about the positive response of individuals with autism on cannabis oil, the doctors still cannot prescribe this due to the lack of scientific study and clinical data. In addition, autism is a complex disorder. A treatment that works on one person with autism may not necessarily work with another.
Missing research has paved the way to the anecdotal evidence that kids with autism are feeling healthier and happier due to cannabis oil. Medical professionals believe that anecdotes are important and it should never be dismissed. It serves as a sign that attention on the matter is demanded and it needs to be disproven or proven.
The Challenge in Exploring Cannabis as Medicine
Perhaps the biggest challenge that we need to overcome in the cannabis oil industry is to remove the issue that cannabis is a dangerous substance. Cannabis is a substance that was widely-used in the medical industry in the Western country during the 19th century. While it may be true that there is limited research about the toxicity level of cannabis on children, there are also no toxicity studies on the common child medication such as risperidone!
The high cost that is associated with the controlled study could amount to more than $800 million which is not viable for many small drug companies planning to develop and distribute the product via a doctors prescription pad. However, there are small ongoing research projects that are being conducted all over the world in order to specify the benefits of CBD oil to individuals with autism. For instance, a clinical psychologist named Giovanni Martinez revealed the positive results of using cannabis oil. He reported that a kid with autism has allegedly spoken his first word after being sprayed with hemp oil for twice a day. In as little as three weeks, the child was able to develop decent language skills.
Strong evidence on the positive impact of CBD oil on autism was reported by Mieko Perez. Her son which was diagnosed with autism has also developed muscular dystrophy and had to ingest 13 types of medication which can be damaging. After a small amount of research, Perez stumbled upon the benefits of cannabis oil and start administering it to her son. Up to this day, her son has been enjoying his life. Despite this positive effect, Perez has received criticism for using cannabis oil on his son.
In Israel Abigail Dar, an activist promoting rights for children and adults diagnosed with Autism Spectrum Disorder (ASD), is the parental force behind a multi-national movement to add autism as a qualifying condition to Israel’s medical marijuana (MMJ) program. Mother to a young adult with severe autism, Dar is involved in promoting clinical research—tracking children and adults who receive whole-plant extract cannabis oil treatments under a preclinical study that could pave the way for autism patients around the world.
Israel is known for decades of groundbreaking cannabis research, and it’s led to the creation of a number of synthesized cannabinoid pharmaceuticals. But Dar believes what’s really needed is unbiased, clinical research on the whole-plant efficacy of cannabis in treating people with autism. So, she started a fundraiser, to both help raise money and promote awareness.
CLINICAL STUDY RESOURCES:
- Endocannabinoid Signaling in Autism
- Mutations found in individuals with autism interfere with endocannabinoid signaling in the brain
- Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders
- A novel approach to the symptomatic treatment of autism
- Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders
- Targeting the endocannabinoid system in the treatment of fragile X syndrome
- Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling